Background A high proportion of Extended-Spectrum-Beta-Lactamase (ESBL) producing
Enterobacteriaceae is causing common infections in all regions of the world. The burden of …

Background Assessment of the burden of disease due to antimicrobial-resistant Escherichia
coli infections facilitates understanding the scale of the problem and potential impacts, and …

Background Community-acquired extended-spectrum beta-lactamase–producing
Enterobacteriaceae (ESBL) infections are an evolving public health problem. Identifying …

Objective To study the clinical characteristics and associated risk factors of infections caused
by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. Methods A case …

Context Severe bacterial infections are not considered as a leading cause of death in young
children in sub-Saharan Africa. The worldwide emergence of extended-spectrum beta …

Extended spectrum β‐lactamase (ESBL) and plasmid‐mediated AmpC β‐lactamase
(pAmpC) producing Escherichia coli have been shown to be present in humans and animals …

Background Extraintestinal pathogenic Escherichia coli (ExPEC) is an important bacterium
and responsible for many bloodstream infections, including urinary tract infections and even …

(1) Background: Risk factors for extended-spectrum beta-lactamase (ESBL) infections could
vary geographically. The purpose of this study was to identify local risk factors for ESBL …

Summary Background The incidence of Escherichia coli bacteraemia in England is
increasing amid concern regarding the roles of antimicrobial resistance and nosocomial …

Objective Risk factors and outcomes associated with extended-spectrum beta-lactamase
(ESBL)-producing Escherichia coli (E. coli) bloodstream infections (BSI) are not yet fully …